Sawai Group Holdings Co., Ltd. (TYO:4887)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Manufacturing and Sale of Pharmaceutical and Other Products	201.68B	189.02B	176.86B	-	-
Manufacturing and Sale of Pharmaceutical and Other Products Growth	6.69%	6.88%	-	-	-
Japan Business	-	-	-	163.70B	163.84B
Japan Business Growth	-	-	-	-0.08%	6.68%
US	-	-	-	36.64B	29.98B
US Growth	-	-	-	22.24%	-10.88%
Total	201.68B	189.02B	176.86B	200.34B	193.82B
Total Growth	6.69%	6.88%	-11.72%	3.37%	3.52%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Japan	201.68B	189.02B	176.86B	163.70B	163.84B
Japan Growth	6.69%	6.88%	8.04%	-0.08%	6.68%
United States of America	-	-	-	36.51B	29.85B
United States of America Growth	-	-	-	22.32%	-11.09%
Other	-	-	-	137.00M	130.00M
Other Growth	-	-	-	5.38%	94.03%
Total	201.68B	189.02B	176.86B	200.34B	193.82B
Total Growth	6.69%	6.88%	-11.72%	3.37%	3.52%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 16, 2026

Data Sources Report a data error